**6. Conclusion**

The development of lower-cost, high-throughput genome-wide genetic screening technolo‐ gies has revolutionized the field of genetic evaluation and now provides clinical geneticists and researchers the opportunity to detect genetic variation in ASD individuals like never be‐ fore. In doing so, the evidence for previously identified genetic susceptibility factors will ex‐ pand, and novel ASD candidate genes and genomic loci will be identified, resulting in a better understanding of the genetic basis of ASD. However, precautions must be taken to ensure that genetic screening results are interpreted and reported properly.
